Chromosome Aberration Reference Info

Ref. No

12053

Title

Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure.

Authors

Quintas-Cardama A

Kantarjian H

Jones D

Nicaise C

O'Brien S

Giles F

Talpaz M

Cortes J

Journal

Blood

Volume

109:497-499

Year

2007